Tevogen Bio Holdings Inc. (NASDAQ:TVGNW) Short Interest Up 181.6% in December

Tevogen Bio Holdings Inc. (NASDAQ:TVGNW) saw a significant growth in short interest during the month of December. As of December 15th, there was short interest totalling 105,600 shares, a growth of 181.6% from the November 30th total of 37,500 shares. Based on an average daily trading volume, of 133,500 shares, the days-to-cover ratio is presently 0.8 days.

Tevogen Bio Stock Up 10.3 %

Shares of TVGNW stock opened at $0.06 on Friday. Tevogen Bio has a 1-year low of $0.01 and a 1-year high of $0.28. The company has a 50-day moving average of $0.06 and a two-hundred day moving average of $0.04.

Tevogen Bio Company Profile

Tevogen Bio Holdings Inc operates as a clinical-stage specialty immunotherapy company that develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment and prevention of chronic lingering symptoms of the disease (Long COVID), as well as COVID-19 in B cell immune suppressed acute COVID-19 patients without a B cell cancer indication, elderly and infirm acute COVID-19 patients, and acute COVID-19 in patients on T cell suppressing drugs, including solid organ transplant patients.